Innovent Biologics

Innovent Biologics is a leading biopharmaceutical company based in China, specializing in the discovery, development, manufacturing, and commercialization of high-quality biologics for the treatment of oncology, metabolic, autoimmune, and other major diseases. They generate revenue through the sales of their innovative drugs, strategic partnerships, and licensing agreements. Founded in 2011, Innovent has rapidly grown, achieving significant milestones such as the development of TYVYT® (sintilimab injection), which has been approved in China for treating various cancers. Their commitment to innovation and patient-centric approach has positioned them as a key player in the global biopharmaceutical industry.

Recent Posts by Innovent Biologics

1-20 of 40